Evidence map›Paper›PMID 30178272›Full record

ArticleJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2019

How do we establish cardiac sympathetic nervous system imaging with

Mark I Travin, Ichiro Matsunari, Gregory S Thomas, Kenichi Nakajima, Keiichiro Yoshinaga

2 registry-linked trialsAbstract read
PubMed Publisher
In one paragraph

Article in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03775096 phase2active not recruitingnot on this map

The Effect of Adrenergic Blocker Therapy on Cardiac and Striatal Transporter Uptake in Pre-Motor and Symptomatic Parkinson's Disease

TypeinterventionalSponsorMichele Tagliati, MDRan2019 to 2026Enrolled15ConditionsREM Sleep Behavior Disorder, Pre-motor Parkinson Disease, Symptomatic Parkinson DiseaseArmsCarvedilol
NCT05109364 phase2active not recruitingnot on this mapstarted 2022, after this paper: background citation

The Effect of alpha1- Adrenergic Receptor Antagonist Therapy on Cardiac and Striatal Transporter Uptake in Pre-Motor and Symptomatic Parkinson's Disease: A Follow up Study

TypeinterventionalSponsorCedars-Sinai Medical CenterRan2022 to 2026Enrolled15ConditionsSymptomatic Parkinson Disease, REM Sleep Behavior Disorder, Pre-motor Parkinson's DiseaseArmsTerazosin therapy
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Diagnostic Efficacy ofDiagnostics (Basel, Switzerland) · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Machine learning-based prediction of conversion coefficients for I-123 metaiodobenzylguanidine heart-to-mediastinum ratio.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023
    Article
  8. Optimal Protocol and Clinical Usefulness ofNuclear medicine and molecular imaging · 2023
    Article
  9. Article
  10. Review
  11. Research progress in the early diagnosis of Parkinson's disease.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Review
  12. Heart rate response to vasodilator stress: A potential new application for a proven prognostic parameter.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  13. The role of neuroimaging in Parkinson's disease.Journal of neurochemistry · 2021
    Review
  14. CardiacJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  15. Review
  16. Prognostic value of cardiacESC heart failure · 2021
    Observational
  17. Article
  18. Expanding the clinical potential of cardiac radionuclide adrenergic imaging.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 2 countries.

Mark I TravinDepartment of Radiology/Division of Nuclear Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
Ichiro MatsunariDivision of Nuclear Medicine, Department of Radiology, Saitama Medical University, Moroyama, Japan.
Gregory S ThomasMemorial Care Heart, & Vascular Institute, Long Beach Medical Center, Long Beach, CA, USA.
Kenichi NakajimaDepartment of Nuclear Medicine, Kanazawa University Hospital, Kanazawa, Japan.
Keiichiro YoshinagaDiagnostic and Therapeutic Nuclear Medicine, National Institutes for Quantum and Radiological Science and Technology, National Institute of Radiological Sciences, Chiba, Japan. yoshinaga.keiichiro@qst.go.jp.
Albert Einstein College of Medicine · USKanazawa University Hospital · JPNational Institutes for Quantum and Radiological Science and Technology · JPSaitama Medical University · JPUniversity of California, Irvine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiac denervation is associated with progressive left ventricular (LV) dysfunction, ventricular arrhythmias, and sudden cardiac death (SCD) in heart failure (HF). In this regard, it is important to evaluate cardiac-specific sympathetic nervous system (SNS) function. The radiotracer Iodine-123 meta-iodobenzylguanidine (

Indexed as

3-IodobenzylguanidineRadiopharmaceuticalsTomography, Emission-Computed, Single-PhotonArrhythmias, CardiacHeart FailureHumansJapanSympathetic Nervous SystemUnited States3-IodobenzylguanidineRadiopharmaceuticals123I-mIBG imagingguidelinesheart failuresympathetic nervous activityventricular arrhythmias

Identifiers

PMID30178272
OpenAlexW2889471340

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.